p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.

Kudahetti, S; Fisher, G; Ambroisine, L; Foster, C; Reuter, V; Eastham, J; Møller, H; Kattan, MW; Cooper, CS; Scardino, P; +2 more... Cuzick, J; Berney, DM; (2009) p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU international, 104 (1). pp. 20-4. ISSN 1464-4096 DOI: https://doi.org/10.1111/j.1464-410X.2009.08407.x

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/j.1464-410X.2009.08407.x

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar